Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (AVHHL) Total Liabilities (2019 - 2025)

Historic Total Liabilities for AVITA Medical (AVHHL) over the last 7 years, with Q4 2025 value amounting to $73.0 million.

  • AVITA Medical's Total Liabilities fell 256.91% to $73.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $73.0 million, marking a year-over-year decrease of 256.91%. This contributed to the annual value of $73.0 million for FY2025, which is 256.91% down from last year.
  • According to the latest figures from Q4 2025, AVITA Medical's Total Liabilities is $73.0 million, which was down 256.91% from $70.4 million recorded in Q3 2025.
  • Over the past 5 years, AVITA Medical's Total Liabilities peaked at $75.0 million during Q4 2024, and registered a low of $8.7 million during Q1 2022.
  • Its 5-year average for Total Liabilities is $37.6 million, with a median of $16.9 million in 2023.
  • In the last 5 years, AVITA Medical's Total Liabilities tumbled by 511.81% in 2022 and then surged by 37729.62% in 2023.
  • Quarter analysis of 5 years shows AVITA Medical's Total Liabilities stood at $11.4 million in 2021, then rose by 13.84% to $13.0 million in 2022, then surged by 377.3% to $61.9 million in 2023, then increased by 21.13% to $75.0 million in 2024, then fell by 2.57% to $73.0 million in 2025.
  • Its Total Liabilities was $73.0 million in Q4 2025, compared to $70.4 million in Q3 2025 and $71.0 million in Q2 2025.